Babson Diagnostics (Babson), a transformative medical technology company improving customer access to diagnostic blood testing, was named one of Fierce Medtech’s elite “Fierce 15.” The honor recognizes Babson as one of the most promising private companies in the global healthcare industry. In the year of COVID-19, Fierce Medtech, a leading daily digital news publication, examined how med tech companies are addressing the most pressing public health challenges.

The conventional diagnostic blood testing experience has not changed notably since it was created 70 years ago. Babson Diagnostics is the first company to present a true alternative to venipuncture, with novel technology designed to use small fingertip samples less than one-tenth the volume without sacrificing quality, accuracy, or menu breadth. Babson will deploy its proprietary technological ecosystem at accessible retail locations such as pharmacy counters throughout the country, giving customers the benefit of longer hours of operation, low out-of-pocket costs, and a more humane experience.

“Babson Diagnostics is honored to be among this select group of Fierce Medtech innovators,” said David Stein, Ph.D., Babson’s CEO. “COVID-19 reinforced that there is an urgent need to shift diagnostic blood testing from centralized collection sites to decentralized, accessible locations. We are proud that Fierce Medtech recognized Babson for our progress toward improving customer health by expanding access to care.”

Babson has partnered with world-leading medical technology companies BD (Becton, Dickinson and Company) and Siemens Healthineers in a shared mission of expanding access to diagnostic blood testing and supporting earlier identification of risks for chronic and non-communicable diseases.

To demonstrate the accuracy of its novel technology, Babson recently conducted the pivotal clinical study “Dandelion Alpha,” which compared its sample collection, sample handling, and analysis technology to conventional blood testing technology in a retail setting and produced strongly correlated test results.

“Initial clinical data reinforces the potential to test a full set of routine diagnostic blood panels from a small capillary sample collected in a convenient retail setting and produce accurate, diagnostic-quality results,” says Stein. “By improving the customer experience of blood testing and removing barriers to access, we hope to help customers engage with their health and achieve their personal health goals.”

The Fierce 15 celebrates the spirit of being “fierce” — championing innovation and creativity, even in the face of intense competition. This is Fierce Medtech’s 9th annual Fierce 15 selection. This year’s full list of winners can be viewed online at https://www.fiercebiotech.com/special-report/fierce-medtech-s-2020-fierce-15.

“Each member of this year’s class of Fierce 15 stands out in a different way, but they all overcame a year of unforgettable obstacles, making each of their successes that much more significant — and all have the potential to deliver changes in healthcare that promise to outlast this pandemic,” said Conor Hale, associate editor of Fierce Medtech.

An internationally recognized daily report reaching a network of over 90,000 med tech industry professionals, Fierce Medtech provides subscribers with an authoritative analysis of the day's top stories. Every year, Fierce Medtech evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors including the strength of its technology, partnerships, venture backers, and a competitive market position.

This episode is sponsored by the Ultiguard Safe Pack. UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy., Learn more about the UltiGuard Safe Pack: https://www.ulticare.com/ultiguard-safe-pack/podcast

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.babsondx.com%2F&amp;esheet=52392847&amp;newsitemid=20210309005309&amp;lan=en-US&amp;anchor=Babson+Diagnostics&amp;index=1&amp;md5=c21cca27b9106c7f6e725e67746017f1">Babson Diagnostics</a>&nbsp;(Babson), a transformative medical technology company improving customer access to diagnostic blood testing, was named one of Fierce Medtech&rsquo;s elite &ldquo;Fierce 15.&rdquo; The honor recognizes Babson as one of the most promising private companies in the global healthcare industry. In the year of COVID-19, Fierce Medtech, a leading daily digital news publication, examined how med tech companies are addressing the most pressing public health challenges.
The conventional diagnostic blood testing experience has not changed notably since it was created 70 years ago. Babson Diagnostics is the first company to present a true alternative to venipuncture, with novel technology designed to use small fingertip samples less than one-tenth the volume without sacrificing quality, accuracy, or menu breadth. Babson will deploy its proprietary technological ecosystem at accessible retail locations such as pharmacy counters throughout the country, giving customers the benefit of longer hours of operation, low out-of-pocket costs, and a more humane experience.
&ldquo;Babson Diagnostics is honored to be among this select group of Fierce Medtech innovators,&rdquo; said David Stein, Ph.D., Babson&rsquo;s CEO. &ldquo;COVID-19 reinforced that there is an urgent need to shift diagnostic blood testing from centralized collection sites to decentralized, accessible locations. We are proud that Fierce Medtech recognized Babson for our progress toward improving customer health by expanding access to care.&rdquo;
Babson has partnered with world-leading medical technology companies BD (<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bd.com%2Fen-us&amp;esheet=52392847&amp;newsitemid=20210309005309&amp;lan=en-US&amp;anchor=Becton%2C+Dickinson+and+Company&amp;index=2&amp;md5=e879b5a3c4f4b9c40fa4d168fb0295bf">Becton, Dickinson and Company</a>) and&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.siemens-healthineers.com%2F&amp;esheet=52392847&amp;newsitemid=20210309005309&amp;lan=en-US&amp;anchor=Siemens+Healthineers&amp;index=3&amp;md5=454a308c71dd241c1ef173c216a9cc07">Siemens Healthineers</a>&nbsp;in a shared mission of expanding access to diagnostic blood testing and supporting earlier identification of risks for chronic and non-communicable diseases.
To demonstrate the accuracy of its novel technology, Babson recently conducted the pivotal clinical study &ldquo;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.babsondx.com%2Fpress-news%2Fbabson-diagnostics-first-to-conduct-full-blood-panel-testing-from-a-finger-sample-in-a-retail-setting&amp;esheet=52392847&amp;newsitemid=20210309005309&amp;lan=en-US&amp;anchor=Dandelion+Alpha&amp;index=4&amp;md5=d2859811326d7b3af2e0e03b7e74f537">Dandelion Alpha</a>,&rdquo; which compared its sample collection, sample handling, and analysis technology to conventional blood testing technology in a retail setting and produced strongly correlated test results.
&ldquo;Initial clinical data reinforces the potential to test a full set of routine diagnostic blood panels from a small capillary sample collected in a convenient retail setting and produce accurate, diagnostic-quality results,&rdquo; says Stein. &ldquo;By improving the customer experience of blood testing and removing barriers to access, we hope to help customers engage with their health and achieve their personal health goals.&rdquo;
The Fierce 15 celebrates the spirit of being &ldquo;fierce&rdquo; &mdash; championing innovation and creativity, even in the face of intense competition. This is Fierce Medtech&rsquo;s 9th annual Fierce 15 selection. This year&rsquo;s full list of winners can be viewed online at&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fiercebiotech.com%2Fspecial-report%2Ffierce-medtech-s-2020-fierce-15&amp;esheet=52392847&amp;newsitemid=20210309005309&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.fiercebiotech.com%2Fspecial-report%2Ffierce-medtech-s-2020-fierce-15&amp;index=5&amp;md5=8b866ef1e3509846299fcc49cb92676d">https://www.fiercebiotech.com/special-report/fierce-medtech-s-2020-fierce-15</a>.
&ldquo;Each member of this year&rsquo;s class of Fierce 15 stands out in a different way, but they all overcame a year of unforgettable obstacles, making each of their successes that much more significant &mdash; and all have the potential to deliver changes in healthcare that promise to outlast this pandemic,&rdquo; said Conor Hale, associate editor of Fierce Medtech.
An internationally recognized daily report reaching a network of over 90,000 med tech industry professionals, Fierce Medtech provides subscribers with an authoritative analysis of the day's top stories. Every year, Fierce Medtech evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors including the strength of its technology, partnerships, venture backers, and a competitive market position.
This episode is sponsored by the Ultiguard Safe Pack.&nbsp;UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container.&nbsp;Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy.,&nbsp;Learn more about the UltiGuard Safe Pack:&nbsp;<a href="https://www.ulticare.com/ultiguard-safe-pack/podcast">https://www.ulticare.com/ultiguard-safe-pack/podcast</a>

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.

The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.

The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.

The definition of “Innovation” is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare & the PPN is the Pharmacist's biggest fan. 

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.
The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.
The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.
The definition of &ldquo;Innovation&rdquo; is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare &amp; the PPN is the Pharmacist's biggest fan.&nbsp;

Pharmacy Podcast Network

The Pharmacy Podcast Network (PPN) is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading pharmacy care. We are proud to have gathered more than 40 different hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and the patients we serve.

The PPN started in March of 2009 and has generated more than 2,000+ episodes publishing 6 to 7 days per week with over 140K+ listeners per month. The PPN was the first podcast to release continuing education for pharmacists in 2019 and was voted 'Healthcare Podcast of the Year' in 2022 by the Healthcare and IT Marketing Community (HITMC).

We're exploring the profession of pharmacy through audio. Pharmacists are our favorite Providers.

Pharmacy Podcast Network™ is a registered trademark

The Pharmacy Podcast Network (PPN) is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading pharmacy care. We are proud to have gathered more than 40 different hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and the patients we serve. The PPN started in March of 2009 and has generated more than 2,000+ episodes publishing 6 to 7 days per week with over 140K+ listeners per month. The PPN was the first podcast to release continuing education for pharmacists in 2019 and was voted 'Healthcare Podcast of the Year' in 2022 by the Healthcare and IT Marketing Community (HITMC). We're exploring the profession of pharmacy through audio. Pharmacists are our favorite Providers.
Pharmacy Podcast Network&trade; is a registered trademark